Using data to fight antibiotic-resistant infections in Africa
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)
This project combines lab testing of bacterial samples and data analysis to find and track drug-resistant infections that make people—especially newborns and hospitalized patients—very sick in African hospitals.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Redeemer's University NIH-funded |
| Lab location | 1 site (Ede, NIGERIA) |
| Project ID | NIH-11162373 on NIH RePORTER |
What this research studies
From your point of view, researchers will collect bacteria from blood, urine, and sputum samples at participating hospitals and test them in the lab, including genetic tests to find resistance genes. They will link those results with clinical records and use data science tools to map where resistant bugs are spreading and which antibiotics no longer work. The team is working with archived samples already collected in Nigeria and Rwanda and will expand real-time surveillance at sentinel sites. The goal is to share actionable information with hospitals to help doctors pick better treatments and stop deadly outbreaks, particularly in newborn units.
Who could benefit from this research
Good fit: Ideal participants are hospitalized patients (particularly newborns and mothers) at participating hospitals in Nigeria and Rwanda who have blood, urine, or respiratory infections and can provide clinical samples or allow their records to be used.
Not a fit: People treated outside participating hospitals, those without bacterial infections, or those unable or unwilling to provide samples or consent are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could help patients get the right antibiotics faster and reduce deadly outbreaks of resistant infections, especially among newborns.
How similar studies have performed: Genome-based surveillance and outbreak tracking have reduced resistant infections in some high-income settings, but large-scale genomic and data-science surveillance in African hospital networks is less established and partly novel.
Where this research is happening
Ede, NIGERIA
- Redeemer's University — Ede, Nigeria (Active)
Researchers
- Principal investigator: Happi, Christian T. — Redeemer's University
- Study coordinator: Happi, Christian T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.